A. Nagata, M. Igarashi, S. Jinno, K. Suto, and H. Okayama, An additional homolog of the fission yeast cdc25 + gene occurs in humans and is highly expressed in some cancer cells, New Biol, vol.3, pp.959-968, 1991.

K. Galaktionov and D. Beach, Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: Evidence for multiple roles of mitotic cyclins, Cell, vol.67, issue.6, pp.1181-1194, 1991.
DOI : 10.1016/0092-8674(91)90294-9

R. Boutros, V. Lobjois, and B. Ducommun, CDC25 phosphatases in cancer cells: key players? Good targets?, Nature Reviews Cancer, vol.20, issue.7, pp.495-507, 2007.
DOI : 10.1158/0008-5472.CAN-05-1054

URL : https://hal.archives-ouvertes.fr/hal-00317350

E. B. Fauman and M. A. Saper, Structure and function of theprotein tyrosine phosphatases, Trends in Biochemical Sciences, vol.21, issue.11, pp.413-417, 1996.
DOI : 10.1016/S0968-0004(96)10059-1

J. W. Eckstein, Cdc25 protein phosphatase: regulation and its role in cancer, Gene Ther. Mol. Biol, vol.1, pp.707-711, 1998.

K. Kristjansdottir and J. Rudolph, Cdc25 Phosphatases and Cancer, Chemistry & Biology, vol.11, issue.8, pp.1043-1051, 2004.
DOI : 10.1016/j.chembiol.2004.07.007

H. Sasaki, H. Yukiue, Y. Kobayashi, M. Tanahashi, S. Moriyama et al., Expression of the cdc25B gene as a prognosis marker in non-small cell lung cancer, Cancer Letters, vol.173, issue.2, pp.187-192, 2001.
DOI : 10.1016/S0304-3835(01)00669-3

M. G. Cangi, B. Cukor, P. Soung, S. Signoretti, G. Moreira et al., Role of the Cdc25A phosphatase in human breast cancer, Journal of Clinical Investigation, vol.106, issue.6, pp.753-761, 2000.
DOI : 10.1172/JCI9174

M. Broggini, G. Buraggi, A. Brenna, L. Riva, A. M. Codegoni et al., Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients, Anticancer Res, vol.20, pp.4835-4840, 2000.

J. Sohn, B. Kiburz, Z. Li, L. Deng, A. Safi et al., Inhibition of Cdc25 Phosphatases by Indolyldihydroxyquinones, Journal of Medicinal Chemistry, vol.46, issue.13, pp.46-2580, 2003.
DOI : 10.1021/jm0300835

M. Brisson, T. Nguyen, A. Vogt, J. Yalowich, A. Giorgianni et al., Discovery and Characterization of Novel Small Molecule Inhibitors of Human Cdc25B Dual Specificity Phosphatase, Molecular Pharmacology, vol.66, issue.4, pp.66-824, 2004.
DOI : 10.1124/mol.104.001784

K. E. Pestell, A. P. Ducruet, P. Wipf, and J. Lazo, Small molecule inhibitors of dual specificity protein phosphatases, Oncogene, vol.19, issue.56, pp.6607-6612, 2000.
DOI : 10.1021/bi00255a007

M. Brisson, T. Nguyen, P. Wipf, B. Joo, B. W. Day et al., Redox regulation of Cdc25B by cell active quinolinediones, Molecular Pharmacology, pp.68-1810, 2005.
DOI : 10.1124/mol.105.016360

J. S. Lazo, D. C. Aslan, E. C. Southwick, K. A. Cooley, A. P. Ducruet et al., Discovery and Biological Evaluation of a New Family of Potent Inhibitors of the Dual Specificity Protein Phosphatase Cdc25, Journal of Medicinal Chemistry, vol.44, issue.24, pp.44-4042, 2001.
DOI : 10.1021/jm0102046

M. C. Brezak, M. Quaranta, and O. Mondésert, A Novel Synthetic Inhibitor of CDC25 Phosphatases, Cancer Research, vol.64, issue.9, pp.3320-3325, 2004.
DOI : 10.1158/0008-5472.CAN-03-3984

URL : https://hal.archives-ouvertes.fr/hal-00317444

L. Brault and D. Bagrel, Activity of novel Cdc25 inhibitors and preliminary evaluation of their potentiation of chemotherapeutic drugs in human breast cancer cells, Life Sciences, vol.82, issue.5-6, pp.315-323, 2008.
DOI : 10.1016/j.lfs.2007.12.001

E. Viry, A. Anwar, G. Kirsch, C. Jacob, M. Diederich et al., Antiproliferative effect of natural tetrasulfides in human breast cancer cells is mediated through the inhibition of the cell division cycle 25 phosphatases, Int. J. Oncol, pp.38-1103, 2011.

M. C. Brezak, M. Quaranta, M. O. Contour-galcera, O. Lavergne, O. Mondesert et al., Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases, Molecular Cancer Therapeutics, vol.4, issue.9, pp.1378-1387, 2005.
DOI : 10.1158/1535-7163.MCT-05-0168

URL : https://hal.archives-ouvertes.fr/hal-00317405

P. Hannewald, B. Maunit, and J. F. Muller, Tubulin-Binding Drug Screening by MALDI-TOFMS, Analytical Chemistry, vol.78, issue.13, pp.4390-4397, 2006.
DOI : 10.1021/ac0601462

P. Hannewald, B. Maunit, and J. Muller, Screening of DHFR-binding drugs by MALDI-TOFMS, Analytical and Bioanalytical Chemistry, vol.31, issue.7-8, pp.1335-1344, 2008.
DOI : 10.1093/toxsci/52.2.111

L. Pu, A. Amoscato, M. Bier, and J. Lazo, Dual G1 and G2 phase inhibition by a novel, selective Cdc25 inhibitor 6-chloro-7-(2-morpholin-4-ylethylamino)- quinoline-5,8-dione, J. Biol. Chem, pp.277-46877, 2002.

H. Kato, M. Okamoto, K. Yamashita, Y. Nakamura, Y. Fukumori et al., PEPTIDE-BINDING ASSESSMENT USING MASS SPECTROMETRY AS A NEW SCREENING METHOD FOR SKIN SENSITIZATION, The Journal of Toxicological Sciences, vol.28, issue.1, pp.28-47, 2003.
DOI : 10.2131/jts.28.19

A. F. Soares, O. Nosjean, D. Cozzone, D. Orazio, M. Becchi et al., Covalent binding of 15-deoxy-D 12,14 prostaglandin J2 to PPARc, Biochem. Biophys. Res. Commun, pp.337-521, 2005.

M. C. Pirrung, L. Deng, Z. Li, and K. Park, Synthesis of 2,5-dihydroxy-3-(indol-3- yl)benzoquinones by acid-catalyzed condensation of indoles with 2,5- dichlorobenzoquinone, J. Org. Chem, pp.67-8374, 2002.

D. M. Horn, E. C. Peters, H. Klock, A. Meyers, and A. Brock, Improved protein identification using automated high mass measurement accuracy MALDI FT-ICR MS peptide mass fingerprinting, International Journal of Mass Spectrometry, vol.238, issue.2, pp.189-196, 2004.
DOI : 10.1016/j.ijms.2004.03.016

. Muller, Evaluation of combined matrix-assisted laser desorption/ionization time-of-flight and matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry experiments for peptide mass fingerprinting analysis, Rapid Commun. Mass Spectrom, vol.25, pp.1881-1892, 2011.

S. Valente, E. Bana, E. Viry, D. Bagrel, and G. Kirsch, Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases, Bioorganic & Medicinal Chemistry Letters, vol.20, issue.19, pp.5827-5830, 2010.
DOI : 10.1016/j.bmcl.2010.07.130

M. O. Contour-galcéra, O. Lavergne, M. C. Brezak, B. Ducommun, and G. Prévost, Synthesis of small molecule CDC25 phosphatases inhibitors, Bioorganic & Medicinal Chemistry Letters, vol.14, issue.23, pp.14-5809, 2004.
DOI : 10.1016/j.bmcl.2004.09.041

B. Bogdanov and R. D. Smith, Proteomics by FTICR mass spectrometry: Top down and bottom up, Mass Spectrometry Reviews, vol.120, issue.187, pp.168-200, 2005.
DOI : 10.1016/S0009-2614(02)00149-5

A. G. Marshall, C. L. Hendrickson, and G. S. Jackson, Fourier transform ion cyclotron resonance mass spectrometry: A primer, Mass Spectrometry Reviews, vol.68, issue.166, pp.1-35, 1998.
DOI : 10.1021/ac9604651

P. J. Calba, J. F. Muller, A. Hachimi, P. Laréginie, and R. Guglielmetti, Spirooxazines as a molecular probe for the study of matrix-assisted laser desorption/ionization processes. Part I: Study of the interaction effect between the molecular probe and the matrix, Rapid Communications in Mass Spectrometry, vol.11, issue.14, pp.1602-1611, 1997.
DOI : 10.1002/(SICI)1097-0231(199709)11:14<1602::AID-RCM999>3.0.CO;2-Z

P. Russell and P. Nurse, cdc25+ functions as an inducer in the mitotic control of fission yeast, Cell, vol.45, issue.1, pp.145-153, 1986.
DOI : 10.1016/0092-8674(86)90546-5

E. Fauman and M. Saper, Structure and function of theprotein tyrosine phosphatases, Trends in Biochemical Sciences, vol.21, issue.11, pp.413-417, 1996.
DOI : 10.1016/S0968-0004(96)10059-1

B. Ducommun, G. Draetta, P. Young, and D. Beach, Fission yeast CDC25 is a cell-cycle regulated protein, Biochemical and Biophysical Research Communications, vol.167, issue.1, pp.301-309, 1990.
DOI : 10.1016/0006-291X(90)91765-K

R. Boutros, V. Lobjois, and B. Ducommun, CDC25B Involvement in the Centrosome Duplication Cycle and in Microtubule Nucleation, Cancer Research, vol.67, issue.24, pp.11557-11564, 2007.
DOI : 10.1158/0008-5472.CAN-07-2415

URL : https://hal.archives-ouvertes.fr/hal-00317336

I. Hoffmann and E. Karsenti, The role of cdc25 in checkpoints and feedback controls in the eukaryotic cell cycle, Journal of Cell Science, vol.1994, issue.Supplement 18, pp.75-79, 1994.
DOI : 10.1242/jcs.1994.Supplement_18.11

S. Jinno, K. Suto, and A. Nagata, Cdc25A is a novel phosphatase functioning early in the cell cycle, EMBO J, vol.13, pp.1549-1556, 1994.

S. Mizoguchi and K. Kim, Expression of cdc25 Phosphatases in the Germ Cells of the Rat Testis1, Biology of Reproduction, vol.56, issue.6, pp.1474-1481, 1997.
DOI : 10.1095/biolreprod56.6.1474

B. Gabrielli, C. Souza, D. Tonks, I. Clark, J. Hayward et al., Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells, J Cell Sci, vol.109, pp.1081-1093, 1996.

T. Izumi and J. Maller, Phosphorylation and activation of the Xenopus Cdc25 phosphatase in the absence of Cdc2 and Cdk2 kinase activity., Molecular Biology of the Cell, vol.6, issue.2, pp.215-226, 1995.
DOI : 10.1091/mbc.6.2.215

J. Zwicker, F. Lucibello, and W. La, Cell cycle regulation of the cyclin A, cdc25C, cdc2 genes is based on a common mechanism of transcriptional repression, EMBO J, vol.14, pp.4514-4522, 1995.

R. Boutros, C. Dozier, and B. Ducommun, The when and wheres of CDC25 phosphatases, Current Opinion in Cell Biology, vol.18, issue.2, pp.185-191, 2006.
DOI : 10.1016/j.ceb.2006.02.003

URL : https://hal.archives-ouvertes.fr/hal-00317392

R. Boutros, V. Lobjois, and B. Ducommun, CDC25 phosphatases in cancer cells: key players? Good targets?, Nature Reviews Cancer, vol.20, issue.7, pp.495-507, 2007.
DOI : 10.1158/0008-5472.CAN-05-1054

URL : https://hal.archives-ouvertes.fr/hal-00317350

M. Cangi, B. Cukor, and P. Soung, Role of the Cdc25A phosphatase in human breast cancer, Journal of Clinical Investigation, vol.106, issue.6, pp.753-761, 2000.
DOI : 10.1172/JCI9174

S. Bonin, D. Brunetti, E. Benedetti, N. Gorji, G. Stanta et al., Expression of cyclin-dependent kinases and CDC25a phosphatase is related with recurrences and survival in women with peri-and 12

M. Contour-galcera, A. Sidhu, G. Prevost, D. Bigg, and B. Ducommun, What's new on CDC25 phosphatase inhibitors, Pharmacology & Therapeutics, vol.115, issue.1, pp.1-12, 2007.
DOI : 10.1016/j.pharmthera.2007.03.009

A. Ferguson, L. White, and P. Donovan, Normal Cell Cycle and Checkpoint Responses in Mice and Cells Lacking Cdc25B and Cdc25C Protein Phosphatases, Molecular and Cellular Biology, vol.25, issue.7, pp.2853-2860, 2005.
DOI : 10.1128/MCB.25.7.2853-2860.2005

A. Lincoln, D. Wickramasinghe, and P. Stein, Cdc25b phosphatase is required for resumption of meiosis during oocyte maturation, Nature Genetics, vol.30, issue.4, pp.446-449, 2002.
DOI : 10.1038/ng856

M. Contour-galcera, O. Lavergne, M. Brezak, B. Ducommun, and G. Prevost, Synthesis of small molecule CDC25 phosphatases inhibitors, Bioorganic & Medicinal Chemistry Letters, vol.14, issue.23, pp.5809-5812, 2004.
DOI : 10.1016/j.bmcl.2004.09.041

URL : https://hal.archives-ouvertes.fr/hal-00317432

S. Ham, H. Park, and D. Lim, Studies on Menadione as an Inhibitor of the cdc25 Phosphatase, Bioorganic Chemistry, vol.25, issue.1, pp.33-36, 1997.
DOI : 10.1006/bioo.1996.1052

J. Sohn, B. Kiburz, and Z. Li, Inhibition of Cdc25 Phosphatases by Indolyldihydroxyquinones, Journal of Medicinal Chemistry, vol.46, issue.13, pp.2580-2588, 2003.
DOI : 10.1021/jm0300835

L. Pu, A. Amoscato, M. Bier, and J. Lazo, Dual G1 and G2 phase inhibition by a novel, selective Cdc25 inhibitor 6-chloro-7- [corrected](2-morpholin-4-ylethylamino)-quinoline-5, p.8

G. Cohen and M. Doherty, Free radical mediated cell toxicity by redox cycling chemicals, Br J Cancer, vol.8, pp.46-52, 1987.

T. Monks, R. Hanzlik, G. Cohen, D. Ross, and D. Graham, Quinone chemistry and toxicity, Toxicology and Applied Pharmacology, vol.112, issue.1, pp.2-16, 1992.
DOI : 10.1016/0041-008X(92)90273-U

L. Brault, M. Denanc-e, and E. Banaszak, Synthesis and biological evaluation of dialkylsubstituted maleic anhydrides as novel inhibitors of Cdc25 dual specificity phosphatases, European Journal of Medicinal Chemistry, vol.42, issue.2, pp.243-247, 2007.
DOI : 10.1016/j.ejmech.2006.09.014

E. Viry, A. Anwar, G. Kirsch, C. Jacob, M. Diederich et al., Antiproliferative effect of natural tetrasulfides in human breast cancer cells is mediated through the inhibition of the cell division cycle 25 phosphatases, Int J Oncol, vol.38, pp.1103-1111, 2011.

E. Sibille, E. Bana, W. Chaouni, M. Diederich, D. Bagrel et al., Development of a matrix-assisted laser desorption/ionization???mass spectrometry screening test to evidence reversible and irreversible inhibitors of CDC25 phosphatases, Analytical Biochemistry, vol.430, issue.1, pp.83-91, 2012.
DOI : 10.1016/j.ab.2012.08.006

D. Da-silva, T. Wasselin, and V. Carr-e, Evaluation of combined matrix-assisted laser desorption/ionization time-of-flight and matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry experiments for peptide mass fingerprinting analysis, Rapid Communications in Mass Spectrometry, vol.79, issue.13, pp.1881-1892, 2011.
DOI : 10.1007/s00339-004-2750-7

R. Cailleau, R. Young, M. Olive, W. Reeves, and . Jr, Breast Tumor Cell Lines From Pleural Effusions 2, JNCI: Journal of the National Cancer Institute, vol.53, issue.3, pp.661-674, 1974.
DOI : 10.1093/jnci/53.3.661

H. Soule, J. Vazguez, A. Long, S. Albert, and M. Brennan, A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2, JNCI: Journal of the National Cancer Institute, vol.51, issue.5, pp.1409-1416, 1973.
DOI : 10.1093/jnci/51.5.1409

B. Haegen and J. Van-der-shay, Immortalization of human mammary epithelial cells by SV40 large T-antigen involves a two step mechanism, In Vitro Cellular & Developmental Biology - Animal, vol.8, issue.3, pp.180-182, 1993.
DOI : 10.1128/MCB.9.7.3088

L. Gollahon and J. Shay, Immortalization of human mammary epithelial cells transfected with mutant p53 (273his), Oncogene, vol.12, pp.715-725, 1996.

T. Mosmann, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, Journal of Immunological Methods, vol.65, issue.1-2, pp.55-63, 1983.
DOI : 10.1016/0022-1759(83)90303-4

S. Valente, E. Bana, E. Viry, D. Bagrel, and G. Kirsch, Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases, Bioorganic & Medicinal Chemistry Letters, vol.20, issue.19, pp.5827-5830, 2010.
DOI : 10.1016/j.bmcl.2010.07.130

M. Brun, E. Braud, and D. Angotti, Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity, Bioorganic & Medicinal Chemistry, vol.13, issue.16, pp.4871-4879, 2005.
DOI : 10.1016/j.bmc.2005.05.005

URL : https://hal.archives-ouvertes.fr/hal-00317419

M. Brezak, M. Quaranta, and M. Contour-galcera, Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases, Molecular Cancer Therapeutics, vol.4, issue.9, pp.1378-1387, 2005.
DOI : 10.1158/1535-7163.MCT-05-0168

URL : https://hal.archives-ouvertes.fr/hal-00317405

E. Braud, M. Goddard, and S. Kolb, Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties, Bioorganic & Medicinal Chemistry, vol.16, issue.19, pp.9040-9049, 2008.
DOI : 10.1016/j.bmc.2008.08.009

M. Brezak, A. Valette, and M. Quaranta, IRC-083864, a novel bis quinone inhibitor of CDC25 phosphatases active against human cancer cells, International Journal of Cancer, vol.29, issue.6, pp.1449-1456, 2009.
DOI : 10.4161/cc.7.2.5306

P. Calba, J. Muller, and A. Hachimi, Spirooxazines as a molecular probe for the study of matrix-assisted laser desorption/ionization processes. Part I: Study of the interaction effect between the molecular probe and the matrix, Rapid Communications in Mass Spectrometry, vol.11, issue.14, pp.1602-1611, 1997.
DOI : 10.1002/(SICI)1097-0231(199709)11:14<1602::AID-RCM999>3.0.CO;2-Z

A. Lavecchia, C. Giovanni, D. Novellino, and E. , CDC25 Phosphatase Inhibitors: An Update, Mini-Reviews in Medicinal Chemistry, vol.12, issue.1, pp.62-73, 2012.
DOI : 10.2174/138955712798868940

R. Jänicke, M. Sprengart, M. Wati, and A. Porter, Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with Apoptosis, Journal of Biological Chemistry, vol.15, issue.16, pp.9357-9360, 1998.
DOI : 10.1038/384368a0

C. Blanc, Q. Deveraux, and S. Krajewski, Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells, Cancer Res, vol.60, pp.4386-4390, 2000.

K. Subik, L. Baxter, and T. Strzepek, The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines, Breast Cancer: Basic and Clinical Research, vol.1, pp.35-41, 2010.
DOI : 10.1158/1940-6207.CAPR-08-0037

V. Papanikolaou, D. Iliopoulos, and I. Dimou, The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells, Int J Oncol, vol.35, pp.1141-1149, 2009.

D. Berry, C. Cirrincione, and I. Henderson, Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer, JAMA, vol.295, issue.14, pp.1658-1667, 2006.
DOI : 10.1001/jama.295.14.1658

M. Sui, Y. Huang, B. Park, N. Davidson, and W. Fan, Estrogen Receptor ?? Mediates Breast Cancer Cell Resistance to Paclitaxel through Inhibition of Apoptotic Cell Death, Cancer Research, vol.67, issue.11, pp.5337-5344, 2007.
DOI : 10.1158/0008-5472.CAN-06-4582

D. Brady-west and D. Mcgrowder, Triple negative breast cancer: Therapeutic and prognostic implications, Asian Pac J Cancer Prev, vol.12, pp.2139-2143, 2011.

W. Ying, S. Wang, J. Shi, and Y. Sun, ER???/ER+??breast cancer cell lines exhibited different resistance to paclitaxel through pulse selection, Medical Oncology, vol.25, issue.6, pp.495-502, 2012.
DOI : 10.1159/000077722

M. Riaz, F. Elstrodt, A. Hollestelle, A. Dehghan, J. Klijn et al., Low-risk susceptibility alleles in 40 human breast cancer cell lines, BMC Cancer, vol.6, issue.5, p.236, 2009.
DOI : 10.1371/journal.pbio.0060108

M. Brisson, C. Foster, and P. Wipf, Independent Mechanistic Inhibition of Cdc25 Phosphatases by a Natural Product Caulibugulone, Molecular Pharmacology, vol.71, issue.1, pp.184-192, 2007.
DOI : 10.1124/mol.106.028589

J. Rudolph, Redox Regulation of the Cdc25 Phosphatases, Antioxidants & Redox Signaling, vol.7, issue.5-6, pp.761-767, 2005.
DOI : 10.1089/ars.2005.7.761